Literature DB >> 35079432

Crystal structure and mol-ecular docking study of diethyl 2,2'-({[(1E,1'E)-(hydrazine-1,2-diyl-idene)bis-(methanylyl-idene)]bis-(4,1-phenyl-ene)}bis-(-oxy))di-acetate.

Said Daoui1, Sevgi Kansiz2, Feyzi Alkim Aktas3, Necmi Dege4, Eiad Saif5,6, Noureddine Benchat1, Khalid Karrouchi7.   

Abstract

The title Schiff base, C22H24N2O6, adopts an E configuration. The mol-ecule is planar, the mean planes of the phenyl ring system (r.m.s deviation = 0.0059 Å) forms a dihedral angle of 0.96 (4)° with the mean plane of the phenyl ring moiety (r.m.s deviation = 0.0076 Å). In the crystal, mol-ecules are linked by weak inter-molecular C-H⋯O and C-H⋯N hydrogen bonds into chains extending along the c-axis and b-axis directions, respectively. A mol-ecular docking study between the title mol-ecule and 5-HT2C, which is a G protein receptor and ligand-gated ion channels found in nervous systems (PDB ID: 6BQH) was executed. The experiment shows that it is a good potential agent because of its affinity and ability to stick to the active sites of the receptor. © Daoui et al. 2022.

Entities:  

Keywords:  Schiff base; crystal structure; hydrazine; mol­ecular docking

Year:  2022        PMID: 35079432      PMCID: PMC8739207          DOI: 10.1107/S205698902101344X

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


  10 in total

1.  AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.

Authors:  Oleg Trott; Arthur J Olson
Journal:  J Comput Chem       Date:  2010-01-30       Impact factor: 3.376

2.  Synthesis, antioxidant and analgesic activities of Schiff bases of 4-amino-1,2,4-triazole derivatives containing a pyrazole moiety.

Authors:  K Karrouchi; L Chemlal; J Taoufik; Y Cherrah; S Radi; M El Abbes Faouzi; M Ansar
Journal:  Ann Pharm Fr       Date:  2016-04-20

Review 3.  Recent pharmacological advancements in schiff bases: a review.

Authors:  Ghulam Murtaza; Amara Mumtaz; Farhan Ahmed Khan; Saeed Ahmad; Saira Azhar; Shujaat Ali Khan; Muhammad Najam-Ul-Haq; Muhammad Atif; Shujaat Ali Khan; Aneela Maalik; Saira Azhar; Ghulam Murtaza
Journal:  Acta Pol Pharm       Date:  2014 Jul-Aug       Impact factor: 0.330

4.  5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology.

Authors:  Yao Peng; John D McCorvy; Kasper Harpsøe; Katherine Lansu; Shuguang Yuan; Petr Popov; Lu Qu; Mengchen Pu; Tao Che; Louise F Nikolajsen; Xi-Ping Huang; Yiran Wu; Ling Shen; Walden E Bjørn-Yoshimoto; Kang Ding; Daniel Wacker; Gye Won Han; Jianjun Cheng; Vsevolod Katritch; Anders A Jensen; Michael A Hanson; Suwen Zhao; David E Gloriam; Bryan L Roth; Raymond C Stevens; Zhi-Jie Liu
Journal:  Cell       Date:  2018-02-01       Impact factor: 41.582

5.  Synthesis and evaluation of 2-(2-fluoro-4-hydroxymethyl-5-methoxy-phenoxy)acetic acid as a linker in solid-phase synthesis monitored by gel-phase (19)F NMR spectroscopy.

Authors:  Fredrik K Wallner; Sara Spjut; Dan Boström; Mikael Elofsson
Journal:  Org Biomol Chem       Date:  2007-06-28       Impact factor: 3.876

6.  SHELXT - integrated space-group and crystal-structure determination.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A Found Adv       Date:  2015-01-01       Impact factor: 2.290

7.  Crystal structure refinement with SHELXL.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr C Struct Chem       Date:  2015-01-01       Impact factor: 1.172

8.  Ethyl 2-[(2-oxo-2H-chromen-7-yl)-oxy]acetate.

Authors:  Hoong-Kun Fun; Ching Kheng Quah; Krishnendu Aich; Sangita Das; Shyamaprosad Goswami
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-03-06

9.  The chalcone ethyl 2-[4-(2-{2,4-bis-[(eth-oxy-carbon-yl)meth-oxy]benzo-yl}ethen-yl)phen-oxy]acetate.

Authors:  Xiaofeng Liu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-12-14

10.  The Cambridge Structural Database.

Authors:  Colin R Groom; Ian J Bruno; Matthew P Lightfoot; Suzanna C Ward
Journal:  Acta Crystallogr B Struct Sci Cryst Eng Mater       Date:  2016-04-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.